Jason Hulse Murray Sells 8,771 Shares of PACS Group (NYSE:PACS) Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 8,771 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $45.16, for a total value of $396,098.36. Following the transaction, the chief executive officer owned 54,566,095 shares in the company, valued at $2,464,204,850.20. The trade was a 0.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51.
• On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total transaction of $476,226.67.
• On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
• On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total transaction of $1,046,238.93.
• On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The shares were sold at an average price of $42.69, for a total transaction of $984,943.68.
• On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The stock was sold at an average price of $42.56, for a total transaction of $858,562.88.
• On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The shares were sold at an average price of $42.94, for a total value of $1,021,242.02.
• On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The shares were sold at an average price of $42.39, for a total value of $1,024,015.23.
• On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total value of $2,600,811.60.
• On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The stock was sold at an average price of $43.92, for a total value of $4,010,159.52.

PACS Group Stock Down 5.7%

Shares of NYSE:PACS opened at $42.01 on Wednesday. The business’s 50 day simple moving average is $44.71 and its two-hundred day simple moving average is $39.13. The firm has a market cap of $6.65 billion, a P/E ratio of 24.42, a PEG ratio of 1.39 and a beta of -0.13. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.49.

PACS Group (NYSE:PACS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%.The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. As a group, research analysts forecast that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Institutional Trading of PACS Group

Hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP raised its stake in shares of PACS Group by 370.2% in the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after buying an additional 614,250 shares during the period. 8 Knots Management LLC purchased a new stake in PACS Group in the 4th quarter worth approximately $23,421,000. Sei Investments Co. boosted its stake in PACS Group by 7.4% during the first quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock valued at $11,900,000 after buying an additional 25,462 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after acquiring an additional 89,067 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in PACS Group during the second quarter valued at approximately $8,196,000.

Key PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Wall Street remains constructive on PACS Group. Truist Financial, Oppenheimer, UBS, and JPMorgan have assigned price targets ranging from $57 to $62, while the reported consensus target is $58.80 versus recent trading levels. Analysts cite the company’s growth outlook and maintain an overall “Moderate Buy” rating. PACS Group insider trading and analyst coverage
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.63 versus the $0.54 consensus estimate and revenue of $1.43 billion versus $1.41 billion expected. This supports the case for continued earnings growth in PACS Group’s skilled-nursing and post-acute-care operations.
• Neutral Sentiment: PACS Group presented at the 2026 Jefferies Healthcare Services and Technology Conference on September 15. Management discussed operations and its growth strategy, but the announcement did not disclose new financial guidance or a material business update. PACS Group Jefferies conference announcement
• Negative Sentiment: Director Mark Hancock sold 300,000 shares across September 14–15 for roughly $13.0 million, while CEO Jason Murray sold more than 10,000 shares in the latest reported transactions. The sales add near-term supply and may concern investors, although Hancock and Murray still retain more than 53 million and 54 million shares, respectively; the reported sales represent only small reductions in their holdings. PACS Group director insider sale filing

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on PACS shares. Oppenheimer lifted their price objective on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Royal Bank Of Canada lifted their price target on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. increased their price objective on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Weiss Ratings lowered PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Finally, Truist Financial set a $62.00 price target on PACS Group in a report on Wednesday, September 2nd. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, PACS Group presently has an average rating of “Moderate Buy” and an average price target of $58.80.

About PACS Group

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.